Literature DB >> 27300316

Pattern of Lung Function Is Not Associated with Prior or Future Morbidity in Children with Sickle Cell Anemia.

Robyn T Cohen1, Robert C Strunk2, Mark Rodeghier3, Carol L Rosen4, Fenella Jane Kirkham5, Jane Kirkby6, Michael R DeBaun7.   

Abstract

RATIONALE: Patient factors associated with development of abnormal lung function in children with sickle cell anemia (SCA) have not been fully characterized.
OBJECTIVES: To characterize lung function abnormalities among children with SCA and to determine whether these steady-state lung function results were associated with morbidity before or after testing among children with SCA.
METHODS: This study was part of the prospective National Institutes of Health-funded Sleep and Asthma Cohort Study. Children with HbSS or Hb Sβ(o) (SCA) were enrolled without regard for sickle cell-related comorbidities or diagnosis of asthma. Lung function was measured by spirometry and plethysmography on the same day, when free of acute disease. Standardized asthma symptom questionnaires and review of the medical records were also performed.
MEASUREMENTS AND MAIN RESULTS: A total of 149 children aged 6 to 19 years completed lung function testing, of whom 139 participants had retrospective morbidity data from birth to the test date, and 136 participants were followed prospectively for a median of 4.3 years from the test date. At baseline, percentages with normal, obstructive, restrictive, nonspecific, and mixed lung function patterns were 70, 16, 7, 6, and 1, respectively. Neither retrospective rates of pain nor acute chest syndrome was associated with lung function patterns. Furthermore, baseline lung function pattern was not predictive of future pain or acute chest syndrome episodes.
CONCLUSIONS: The majority of children with SCA have lung function that is within the normal range. Abnormal lung function patterns were not associated with prior vasoocclusive pain or acute chest syndrome episodes, and baseline lung function patterns did not predict future vasoocclusive pain or chest syndrome episodes.

Entities:  

Keywords:  child; pulmonary function tests; respiratory physiological phenomena; risk factors; sickle cell anemia

Mesh:

Year:  2016        PMID: 27300316      PMCID: PMC5021073          DOI: 10.1513/AnnalsATS.201510-706OC

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  39 in total

1.  The impact of recurrent acute chest syndrome on the lung function of young adults with sickle cell disease.

Authors:  Jennifer M Knight-Madden; Terrence S Forrester; Norma A Lewis; Anne Greenough
Journal:  Lung       Date:  2010-07-20       Impact factor: 2.584

2.  Interpretative strategies for lung function tests.

Authors:  R Pellegrino; G Viegi; V Brusasco; R O Crapo; F Burgos; R Casaburi; A Coates; C P M van der Grinten; P Gustafsson; J Hankinson; R Jensen; D C Johnson; N MacIntyre; R McKay; M R Miller; D Navajas; O F Pedersen; J Wanger
Journal:  Eur Respir J       Date:  2005-11       Impact factor: 16.671

3.  Measurement of FEF25-75% and FEF75% does not contribute to clinical decision making.

Authors:  Philip H Quanjer; Daniel J Weiner; Jeffrey J Pretto; Danny J Brazzale; Piotr W Boros
Journal:  Eur Respir J       Date:  2013-09-26       Impact factor: 16.671

4.  Sickle cell chronic lung disease: prior morbidity and the risk of pulmonary failure.

Authors:  D Powars; J A Weidman; T Odom-Maryon; J C Niland; C Johnson
Journal:  Medicine (Baltimore)       Date:  1988-01       Impact factor: 1.889

5.  Does the FEF25-75 or the FEF75 have any value in assessing lung disease in children with cystic fibrosis or asthma?

Authors:  Karl Z Lukic; Allan L Coates
Journal:  Pediatr Pulmonol       Date:  2015-06-16

6.  Prevalence and reversibility of lower airway obstruction in children with sickle cell disease.

Authors:  A C Koumbourlis; H J Zar; A Hurlet-Jensen; M R Goldberg
Journal:  J Pediatr       Date:  2001-02       Impact factor: 4.406

7.  Conditions associated with an abnormal nonspecific pattern of pulmonary function tests.

Authors:  Robert E Hyatt; Clayton T Cowl; Julie A Bjoraker; Paul D Scanlon
Journal:  Chest       Date:  2008-09-23       Impact factor: 9.410

8.  Respiratory muscle force and lung volume changes in a population of children with sickle cell disease.

Authors:  Bruce A Ong; Jason Caboot; Abbas Jawad; Joseph McDonough; Tannoa Jackson; Raanan Arens; Carole L Marcus; Kim Smith-Whitley; Thornton B A Mason; Kwaku Ohene-Frempong; Julian L Allen
Journal:  Br J Haematol       Date:  2013-07-20       Impact factor: 6.998

Review 9.  Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.

Authors:  Barbara P Yawn; George R Buchanan; Araba N Afenyi-Annan; Samir K Ballas; Kathryn L Hassell; Andra H James; Lanetta Jordan; Sophie M Lanzkron; Richard Lottenberg; William J Savage; Paula J Tanabe; Russell E Ware; M Hassan Murad; Jonathan C Goldsmith; Eduardo Ortiz; Robinson Fulwood; Ann Horton; Joylene John-Sowah
Journal:  JAMA       Date:  2014-09-10       Impact factor: 56.272

10.  Pulmonary function abnormalities in children with sickle cell disease.

Authors:  K P Sylvester; R A Patey; P Milligan; M Dick; G F Rafferty; D Rees; S L Thein; A Greenough
Journal:  Thorax       Date:  2004-01       Impact factor: 9.139

View more
  9 in total

1.  Reply: Decline of Lung Function in Children with Sickle Cell Disease Is Not Associated with Restrictive Defects.

Authors:  Robyn T Cohen; Mark Rodeghier; Michael R DeBaun
Journal:  Ann Am Thorac Soc       Date:  2017-03

2.  Asthma Screening in Pediatric Sickle Cell Disease: A Clinic-Based Program Using Questionnaires and Spirometry.

Authors:  Sara C Sadreameli; Rachel O Alade; Peter J Mogayzel; Sharon McGrath-Morrow; John J Strouse
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2017-12-01       Impact factor: 1.349

3.  Primum non nocere: the case against transplant for children with sickle cell anemia without progressive end-organ disease.

Authors:  Michael R DeBaun; Ellen Wright Clayton
Journal:  Blood Adv       Date:  2017-12-08

4.  Age is a predictor of a small decrease in lung function in children with sickle cell anemia.

Authors:  Shaina M Willen; Robyn Cohen; Mark Rodeghier; Fenella Kirkham; Susan S Redline; Carol Rosen; Jane Kirkby; Michael R DeBaun
Journal:  Am J Hematol       Date:  2018-01-25       Impact factor: 10.047

5.  Tricuspid regurgitation velocity and other biomarkers of mortality in children, adolescents and young adults with sickle cell disease in the United States: The PUSH study.

Authors:  Mehdi Nouraie; Deepika S Darbari; Sohail Rana; Caterina P Minniti; Oswaldo L Castro; Lori Luchtman-Jones; Craig Sable; Niti Dham; Gregory J Kato; Mark T Gladwin; Gregory Ensing; Manuel Arteta; Andrew Campbell; James G Taylor; Sergei Nekhai; Victor R Gordeuk
Journal:  Am J Hematol       Date:  2020-04-21       Impact factor: 10.047

6.  American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease.

Authors:  Robert I Liem; Sophie Lanzkron; Thomas D Coates; Laura DeCastro; Ankit A Desai; Kenneth I Ataga; Robyn T Cohen; Johnson Haynes; Ifeyinwa Osunkwo; Jeffrey D Lebensburger; James P Lash; Theodore Wun; Madeleine Verhovsek; Elodie Ontala; Rae Blaylark; Fares Alahdab; Abdulrahman Katabi; Reem A Mustafa
Journal:  Blood Adv       Date:  2019-12-10

7.  Airway Hyperresponsiveness Does Not Predict Morbidity in Children with Sickle Cell Anemia.

Authors:  Shaina M Willen; Mark Rodeghier; Robert C Strunk; Carol L Rosen; Fenella J Kirkham; Joshua J Field; Michael R DeBaun; Robyn T Cohen
Journal:  Am J Respir Crit Care Med       Date:  2017-06-01       Impact factor: 21.405

8.  Identifying Clinical and Research Priorities in Sickle Cell Lung Disease. An Official American Thoracic Society Workshop Report.

Authors:  A Parker Ruhl; S Christy Sadreameli; Julian L Allen; Debra P Bennett; Andrew D Campbell; Thomas D Coates; Dapa A Diallo; Joshua J Field; Elizabeth K Fiorino; Mark T Gladwin; Jeffrey A Glassberg; Victor R Gordeuk; Leroy M Graham; Anne Greenough; Jo Howard; Gregory J Kato; Jennifer Knight-Madden; Benjamin T Kopp; Anastassios C Koumbourlis; Sophie M Lanzkron; Robert I Liem; Roberto F Machado; Alem Mehari; Claudia R Morris; Folasade O Ogunlesi; Carol L Rosen; Kim Smith-Whitley; Danna Tauber; Nancy Terry; Swee Lay Thein; Elliott Vichinsky; Nargues A Weir; Robyn T Cohen; Elizabeth S Klings
Journal:  Ann Am Thorac Soc       Date:  2019-09

Review 9.  Advances in the diagnosis and treatment of sickle cell disease.

Authors:  A M Brandow; R I Liem
Journal:  J Hematol Oncol       Date:  2022-03-03       Impact factor: 17.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.